© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging Options
This Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.
This activity is supported by an educational grant from sanofi-aventis U.S.
Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging Options
Faculty
Jennifer M. Trujillo, PharmD, BCPS, CDE
Associate Professor
University of Colorado
Skaggs School of Pharmacy and
Pharmaceutical Sciences
Aurora, CO
Wesley Nuffer, PharmD, BCPS, CDE
Assistant Professor
Assistant Director of Experiential
Programs
University of Colorado
Skaggs School of Pharmacy and
Pharmaceutical Sciences
Aurora, CO
Educational Objectives
After completing this continuing education program, the participant will be able to:
- Discuss why postprandial hyperglycemia and hypoglycemia occur with existing prandial therapies.
- Review the pharmacokinetic and pharmacodynamic profile, efficacy, and safety of available prandial therapies, as well as those in development.
- Discuss the role of prandial therapies in addressing patient therapeutic needs, as well as the importance of counseling patients on safe and effective drug therapy use.
Target audience:
Pharmacists
Type of activity:
Knowledge
Release date:
June 7, 2015
Expiration date:
June 7, 2017
Fee:
Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-054-H01-P. The activity is available for CE credit through June 7, 2017.
